Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heinz Zoller

Showing results (1-10 of 206) with videos related to

Pageof 21
Sort By:
Advances in Experimental Medicine and Biology|July 2, 2025
Iron and Liver DiseaseHeinz Zoller
Journal of Hepatology|April 17, 2025
Diving deep: Finding pathogenic intronic variants and making them actionableBenedikt Schaefer, Heinz Zoller
Liver International : Official Journal of the International Association for the Study of the Liver|August 11, 2016
Response to Successful liver transplantation for hepatocellular carcinoma following down-staging using sorafenib single therapy by Borentain et alArmin Finkenstedt, Heinz Zoller
Nutrition (Burbank, Los Angeles County, Calif.)|June 24, 2004
Iron supplementation in athletes--first do no harmHeinz Zoller, Wolfgang Vogel
Nature Microbiology|October 16, 2023
Pleiotropic prebiotic for liver diseaseHerbert Tilg, Heinz Zoller
Gut|March 27, 2024
Ferritin-a promising biomarker in MASLDHeinz Zoller, Herbert Tilg
Digestive Diseases (Basel, Switzerland)|May 13, 2016
Pathogenesis, Diagnosis and Treatment of HemochromatosisHeinz Zoller, Benjamin Henninger
Journal of Hepatology|December 8, 2014
Should C282Y homozygotes with mild iron overload be treated?Heinz Zoller, Armin Finkenstedt
Metabolism: Clinical and Experimental|February 25, 2016
Nonalcoholic fatty liver disease and hepatocellular carcinomaHeinz Zoller, Herbert Tilg
International Journal of Nanomedicine|August 28, 2007
Nanomedicines in the treatment of patients with hepatitis C co-infected with HIV--focus on pegylated interferon-alphaHeinz Zoller, Wolfgang Vogel
Pageof 21

Showing results (1-10 of 206) with videos related to

Sort By:
Pageof 21
Advances in Experimental Medicine and Biology|July 2, 2025
Iron and Liver DiseaseHeinz Zoller
Journal of Hepatology|April 17, 2025
Diving deep: Finding pathogenic intronic variants and making them actionableBenedikt Schaefer, Heinz Zoller
Liver International : Official Journal of the International Association for the Study of the Liver|August 11, 2016
Response to Successful liver transplantation for hepatocellular carcinoma following down-staging using sorafenib single therapy by Borentain et alArmin Finkenstedt, Heinz Zoller
Nutrition (Burbank, Los Angeles County, Calif.)|June 24, 2004
Iron supplementation in athletes--first do no harmHeinz Zoller, Wolfgang Vogel
Nature Microbiology|October 16, 2023
Pleiotropic prebiotic for liver diseaseHerbert Tilg, Heinz Zoller
Gut|March 27, 2024
Ferritin-a promising biomarker in MASLDHeinz Zoller, Herbert Tilg
Digestive Diseases (Basel, Switzerland)|May 13, 2016
Pathogenesis, Diagnosis and Treatment of HemochromatosisHeinz Zoller, Benjamin Henninger
Journal of Hepatology|December 8, 2014
Should C282Y homozygotes with mild iron overload be treated?Heinz Zoller, Armin Finkenstedt
Metabolism: Clinical and Experimental|February 25, 2016
Nonalcoholic fatty liver disease and hepatocellular carcinomaHeinz Zoller, Herbert Tilg
International Journal of Nanomedicine|August 28, 2007
Nanomedicines in the treatment of patients with hepatitis C co-infected with HIV--focus on pegylated interferon-alphaHeinz Zoller, Wolfgang Vogel
Pageof 21